We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

46 hedge funds and large institutions have $30.4M invested in NantHealth, Inc in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

1% more capital invested

Capital invested by funds: $29.9M → $30.4M (+$444K)

4% less funds holding

Funds holding: 4846 (-2)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $402K

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.15%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
9
Increased
20
Reduced
10
Closed
11
Calls
Puts
$402K
Net Calls
-$402K
Net Calls Change
+$70K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$10.7M +$2.2M +39,687 +31%
Blackstone Inc
2
Blackstone Inc
New York
$2.52M
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$2.26M -$59.8K -1,079 -3%
EA
4
Emerald Advisers
Pennsylvania
$2.06M -$214K -3,857 -11%
EMFAT
5
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.89M
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.79M +$263K +4,739 +20%
WCM
7
Wildcat Capital Management
New York
$1.01M
HCM
8
Highbridge Capital Management
New York
$993K +$123K +2,228 +17%
Morgan Stanley
9
Morgan Stanley
New York
$788K +$644K +11,613 +1,441%
Goldman Sachs
10
Goldman Sachs
New York
$717K +$299K +5,402 +91%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$715K -$17.7K -320 -3%
Northern Trust
12
Northern Trust
Illinois
$643K +$321K +5,797 +134%
State Street
13
State Street
Massachusetts
$623K +$255K +4,598 +88%
NPC
14
National Planning Corporation
California
$473K +$423K +7,633 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$363K +$44.9K +811 +16%
Renaissance Technologies
16
Renaissance Technologies
New York
$346K -$38.4K -693 -11%
ProShare Advisors
17
ProShare Advisors
Maryland
$271K -$5.32K -96 -2%
DekaBank Deutsche Girozentrale
18
DekaBank Deutsche Girozentrale
Germany
$245K +$205K +3,700 New
Group One Trading
19
Group One Trading
Illinois
$239K +$85.3K +1,540 +69%
TCIM
20
TIAA CREF Investment Management
New York
$202K +$102K +1,843 +137%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$190K +$110K +1,976 +195%
ARTA
22
A.R.T. Advisors
New York
$142K +$125K +2,248 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$134K +$66.5K +1,200 +132%
TA
24
Teachers Advisors
New York
$134K +$90.8K +1,639 +352%
GCP
25
GSA Capital Partners
United Kingdom
$121K +$105K +1,900 New

NH Hedge Fund Activity: Q2 2017 in Review

46 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q2 2017, worth a combined $30.4M — up 1.5% from $29.9M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NH and 9 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 20 added.

The largest buyer was BlackRock, adding an estimated $2.2M. The largest seller was Capital Impact Advisors, exiting entirely with an estimated $583K sold.

  • 46 institutional investors held NantHealth, Inc (NH) as of Q2 2017, down from 48 in Q1 2017.
  • Funds reported $30.4M of NantHealth, Inc stock for Q2 2017, up 1.5% quarter-over-quarter.
  • 9 funds opened new NantHealth, Inc positions in Q2 2017 and 11 closed out, a net change of -2 holders.
  • The largest NantHealth, Inc buyer in Q2 2017 was BlackRock, an estimated $2.2M added.
  • The largest NantHealth, Inc seller in Q2 2017 was Capital Impact Advisors, an estimated $583K sold.

Based on aggregated 13F filings for Q2 2017.